Cargando…
The SpaTemp cohort: 168 nondysplastic Barrett’s esophagus surveillance patients with and without progression to early neoplasia to evaluate the distribution of biomarkers over space and time
The ReBus cohort is a matched nested case–control cohort of patients with nondysplastic (ND) Barrett’s esophagus (BE) at baseline who progressed (progressors) or did not progress (nonprogressors) to high-grade dysplasia (HGD) or cancer. This cohort is constructed using the most stringent inclusion c...
Autores principales: | Frei, N F, Konté, K, Duits, L C, Klaver, E, Ten Kate, F J, Offerhaus, G J, Meijer, S L, Visser, M, Seldenrijk, C A, Schoon, E J, Weusten, B L A M, Schenk, B E, Mallant-Hent, R C, Bergman, J J, Pouw, R E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155949/ https://www.ncbi.nlm.nih.gov/pubmed/32944737 http://dx.doi.org/10.1093/dote/doaa095 |
Ejemplares similares
-
Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis
por: Frei, Nicola F., et al.
Publicado: (2020) -
Management of nondysplastic Barrett’s esophagus: When to survey? When
to ablate?
por: Puthenpura, Max M., et al.
Publicado: (2022) -
Development of benchmark quality criteria for assessing
whole-endoscopy Barrett's esophagus biopsy cases
por: van der Wel, MJ, et al.
Publicado: (2018) -
Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer
por: Dilworth, Mark P., et al.
Publicado: (2019) -
Incidence of Dysplasia in Obese vs Nonobese Patients With Nondysplastic Barrett Esophagus
por: Monardo, Ann, et al.
Publicado: (2019)